Life360 Inc Form 4 Filings

Life360, Inc. (LIF) director James Synge reported open-market sales of the company’s common stock, executed via CHESS Depositary Interests (CDIs) traded on the Australian Securities Exchange. On 2026-08-26, he sold 27,466 common-stock-equivalent shares at a weighted average price of $44.31 per share, with individual sale prices ranging from $44.169 to $44.557. On 2026-08-25, he sold 5,833 common-stock-equivalent shares at a weighted average price of $45.05 per share. The prices were derived from CDI trades using the 3:1 CDI-to-common-stock conversion ratio and exchange rates of 0.715 and 0.7182, respectively. Reported holdings include 4,600 RSUs, each representing one share of common stock upon vesting, and also include common stock underlying CDIs on the same 1:3 basis.

Life360, Inc. (LIF) director Synge James reported option exercises and related share issuances on August 19, 2026. James exercised stock options for 12,203 shares of common stock at an exercise price of $13.35 per share and 21,769 shares at $8.19 per share, with the underlying options fully vested and exercisable. The transactions moved 33,972 shares from derivative (option) holdings into common stock. Footnotes state that reported direct ownership includes 4,600 RSUs and shares underlying Chess Depositary Interests, which trade on the Australian Securities Exchange.

Life360, Inc. (LIF) director Chris Hulls reported a series of option exercises and share sales on 2026-08-18. He exercised stock options for a total of 212,502 shares of common stock at exercise prices of $2.53, $7.28 and $8.19 per share, from fully vested options. On the same date he sold 250,000 shares of common stock in open-market transactions at weighted average prices of $46.78 and $47.58 per share, with individual sale prices ranging from $46.36–$48.30 per share. Following these transactions, indirect holdings of 195,312 shares of common stock are reported for each of three 2023 irrevocable trusts, which represent shares underlying Chess Depositary Interests.

Life360, Inc. director Charles J. Prober exercised a fully vested stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, leaving 23,790 option shares outstanding. He then sold 7,930 common shares at $48.59 per share on the same date. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. Reported equity holdings include 4,474 restricted stock units, each representing one future share upon vesting.

Life360, Inc. director Brit Morin reported an option exercise-and-sale sequence on August 10, 2026. She exercised stock options for a total of 9,765 shares of common stock at exercise prices of $2.15 and $8.19 per share, then sold 15,582 shares of common stock at $65.00 per share. A footnote states these transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and that the reporting person’s holdings include 4,636 restricted stock units representing contingent rights to receive common shares upon vesting.

Life360, Inc. director Morin Brit reported multiple transactions on August 4, 2026. Brit exercised fully vested stock options covering 4,011 shares at $2.15 and 872 shares at $8.19, receiving the same number of common shares. On the same date, Brit sold 10,701 common shares at $60.00 per share pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 13, 2026. Brit’s reported holdings also include 4,636 restricted stock units, each representing a contingent right to one common share upon vesting.

Life360, Inc. director Chris Hulls exercised stock options for 27,000 shares of common stock at $2.53 per share on August 4, 2026, then sold 27,000 shares in two transactions at weighted-average prices of $63.08 and $63.77 under a Rule 10b5-1 trading plan adopted on December 16, 2025. After the exercise, he held 1,215,386 stock options and reported indirect ownership of 195,312 shares of common stock in each of three 2023 irrevocable trusts representing shares underlying Chess Depositary Interests.

Life360, Inc. director John Philip Coghlan reported pre-planned sales of a total of 4,000 shares of common stock on August 3, 2026 by the John Coghlan Living Trust under a Rule 10b5-1 trading plan adopted on December 8, 2025. The trust sold 1,400 shares at a weighted average price of $54.66 (range $53.83–$54.80) and 2,600 shares at a weighted average price of $54.90 (range $54.89–$54.95). After these transactions, Coghlan holds 5,676 shares directly, including 4,840 restricted stock units, and 55,494 shares indirectly through a 2025 Grantor Retained Annuity Trust.

Prober Charles J. reported acquisition or exercise transactions in this Form 4 filing.

Life360, Inc. reported that director Charles J. Prober received a grant of 19 Restricted Stock Units (RSUs) effective August 1, 2026, in connection with his appointment to the Corporate Governance and Nominating Committee. The award represents a pro rata portion of the standard annual committee retainer grant. The RSUs vest in three equal installments on November 15, 2026, February 25, 2027, and May 15, 2027, subject to continuous service, and bring his direct holdings to 109,930 shares, including 4,474 previously granted RSUs.

Life360 director Chris Hulls exercised 27,000 stock options at an exercise price of $2.53 per share, receiving the same number of common shares, then sold 14,345 shares at a weighted average of $55.74 (range $55.46–$56.13) under a Rule 10b5-1 trading plan adopted on December 16, 2025. Following these transactions, he holds 1,242,386 shares directly (including CDIs and 134,496 RSUs), and three 2023 irrevocable family trusts each hold 195,312 shares indirectly.

Life360, Inc. director Charles J. Prober exercised stock options to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares at $53.05 per share in an open-market transaction executed under a pre-established Rule 10b5-1 trading plan.

After these transactions, Prober holds 109,911 shares of common stock directly, plus 4,455 restricted stock units, and retains 31,720 fully vested, exercisable stock options that expire on April 12, 2028.

Life360, Inc. director John Philip Coghlan reported open-market sales of company common stock executed through a related trust. The John Coghlan Living Trust sold a total of 4,000 shares of Life360 common stock in two transactions on July 1, 2026, at weighted average prices of $56.04 and $56.57 per share, under a pre-arranged Rule 10b5-1 trading plan.

After these sales, the John Coghlan Living Trust held 24,431 shares of Life360 common stock. Related indirect holdings also include 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust, while direct holdings total 5,676 shares, including 4,840 restricted stock units that may convert into shares upon vesting.

Life360, Inc. director Morin Brit sold 4,655 shares of common stock in an open-market sale at $55.00 per share on June 29, 2026. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 13, 2026, which automatically executes trades based on preset criteria.

After this sale, Brit directly holds 25,975 shares of Life360 common stock. This total includes 4,636 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock when the RSUs vest, reflecting ongoing stock-based compensation.

Life360 director Chris Hulls reported an option exercise and share sale in Life360, Inc. common stock. On June 18, 2026, he exercised stock options covering 27,000 shares at $8.19 per share and acquired the same number of common shares. On the same date, he sold 16,042 shares in an open-market transaction at a weighted average price of $47.07 per share, executed under a pre-established Rule 10b5-1 trading plan.

After these transactions, Hulls directly holds 406,899 shares of common stock and 125,801 stock options, and also has indirect ownership of additional shares through 2023 irrevocable trusts. The filing notes that his holdings include shares underlying Chess Depositary Interests and 134,496 restricted stock units that may settle into common shares upon vesting.

Life360, Inc. director Charles J. Prober executed an options-related, pre-planned stock sale. He exercised stock options to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares in an open-market transaction at $46.07 per share.

The transactions were carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which provides for automatic sales based on preset criteria. Following these trades, Prober directly holds 109,911 shares of Life360 common stock, indicating he retains a substantial equity position.

Life360, Inc.’s Chief Financial Officer Russell John Burke reported internal changes in how some of his shares are held, rather than market purchases or sales. He transferred 15,000 indirectly held common shares to each of three separate trusts, 45,000 shares in total, in a restructuring classified under transaction code J.

According to the footnote, these transfers were exempt from Section 16 under Rule 16a-13 and Burke retains indirect beneficial ownership of all 45,000 transferred shares. After these updates, his reported holdings include directly held common stock, indirectly held common stock through multiple trusts, and 106,291 restricted stock units, each convertible into one share upon vesting.

Life360, Inc. director Chris Hulls reported routine share activity related to equity compensation. On the Form 4, 7,544 shares of common stock valued at $45.37 per share were withheld by the company to cover income tax obligations when previously granted restricted stock units vested. This is described as a tax-withholding disposition, not an open-market sale.

After this withholding, Hulls directly holds 395,941 shares of common stock. The filing also shows additional indirect holdings through several 2023 irrevocable trusts, each reported with share balances, as well as outstanding restricted stock units that may convert into common stock upon future vesting.

Life360, Inc.'s Chief Financial Officer, Russell John Burke, reported a routine tax-withholding share disposition tied to restricted stock unit vesting. On this Form 4, 6,087 shares of common stock were withheld by the company at $45.37 per share to cover income tax obligations related to previously reported RSUs, and were not sold in the market.

After this withholding, Burke directly holds 115,974 shares of Life360 common stock and also has 113,361 shares held indirectly through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust ELD as tenants in common. The filing also notes 106,291 restricted stock units outstanding, each representing a right to receive one share upon vesting.

Life360, Inc. Chief Executive Officer Lauren Antonoff reported a routine tax-related share withholding. On the RSU vesting date, 21,130 shares of common stock were withheld by the company to cover income tax obligations tied to the net settlement of previously reported restricted stock units.

Following this tax-withholding disposition, Antonoff directly holds 288,651 shares of Life360 common stock. The filing also notes 120,044 RSUs outstanding, each representing a contingent right to receive one share upon future vesting. This event does not represent an open-market sale of shares.

Life360, Inc. director Randi Zuckerberg reported an equity compensation grant in the form of 4,455 shares of common stock, structured as Restricted Stock Units (RSUs) granted at no cash cost per share. These RSUs vest over time, with one quarter of the award vesting quarterly from May 15, 2026, conditioned on her continued service. Following this award, she is shown as directly holding 29,532 shares of common stock, which the disclosure notes includes 5,134 RSUs that each convert into one share upon vesting or settlement.

Life360, Inc. director David Wiadrowski received a grant of 4,816 Restricted Stock Units (RSUs) of common stock at no cash cost. Each RSU represents the right to receive one share upon settlement.

One quarter of the RSUs will vest quarterly starting on May 15, 2026, subject to his continuous service through each vesting date. Following this award, he holds 44,495 shares of common stock in total, which includes 5,554 RSUs and common stock underlying Chess Depositary Interests (CDIs) converted using a 1:3 common stock-to-CDI ratio.

Synge James reported acquisition or exercise transactions in this Form 4 filing.

Life360, Inc. director James Synge received a grant of 4,600 restricted stock units (RSUs) of common stock on May 29, 2026. Each RSU represents a contingent right to one share of Life360 common stock, with one quarter of the award vesting quarterly from May 15, 2026, subject to his continuous service.

Following this grant, Synge directly holds 191,021 shares and RSUs in total, including 5,303 RSUs and shares underlying Chess Depositary Interests (CDIs) on the Australian Securities Exchange, which are convertible at a 1:3 common stock to CDI ratio.

Life360, Inc. director Charles J. Prober received a grant of 4,455 shares of common stock in the form of Restricted Stock Units (RSUs) on May 29, 2026 as equity compensation. The RSUs carry no purchase price and each represents the right to receive one share upon settlement.

According to the terms, one-quarter of the RSUs will vest quarterly starting from May 15, 2026, subject to his continued service through each vesting date. Following this award, Prober directly holds 109,911 shares of Life360 common stock, which includes 5,134 RSUs that each convert into one share upon vesting.

Life360, Inc. director Brit Morin received a grant of 4,636 Restricted Stock Units (RSUs), each representing a right to one share of common stock at no cash cost. One quarter of these RSUs will vest quarterly from May 15, 2026, assuming continued service. Following this award, Morin directly holds 30,630 shares and RSUs in total, which includes 5,345 RSUs that each convert into one share upon vesting.

Life360, Inc. director Alex Haro received a grant of 4,455 Restricted Stock Units (RSUs), each representing a right to receive one share of common stock upon settlement. The award was made at a price of $0.00 per share as equity compensation.

According to the filing, one-quarter of the RSUs will vest quarterly from May 15, 2026, conditioned on Haro’s continued service through each vesting date. After this grant, he holds 1,010,303 shares of common stock, which includes 5,134 RSUs that will convert into shares upon vesting.

Goines Mark reported acquisition or exercise transactions in this Form 4 filing.

Life360, Inc. director Mark Goines reported an equity compensation award and updated share holdings. He received a grant of 5,322 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock upon settlement, with one‑quarter vesting quarterly from May 15, 2026, subject to his continuous service.

After this grant, he holds 11,392 shares of common stock directly, which include 6,102 RSUs. He also reports 56,809 shares held indirectly through the Goines Wong Living Trust. The transactions reflect routine stock-based compensation and updated ownership rather than open-market buying or selling.

Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.

Life360 director Chris Hulls reported option exercises and share sales under a pre‑planned trading arrangement. On May 28, 2026, he exercised stock options for 27,000 shares of common stock at $8.19 per share and sold 16,379 shares in open‑market transactions at a weighted average price of $40.34 per share. The sale was executed pursuant to a Rule 10b5‑1 trading plan adopted in December 2025, meaning the trades followed predetermined criteria rather than discretionary timing.

After these transactions, the filing reports 419,864 shares of common stock held directly and 152,801 stock options remaining outstanding. It also shows 195,312 shares of common stock held indirectly in each of the McKenzie Hulls 2023 Irrevocable Trust, the Rose Hulls 2023 Irrevocable Trust, and the Robin Hulls 2023 Irrevocable Trust, along with 149,318 restricted stock units representing additional contingent rights to shares.

Life360, Inc. director Charles J. Prober exercised stock options and sold shares in a coordinated transaction. He exercised options for 7,930 shares of common stock at $11.18 per share and sold 7,930 shares at $40.44 per share in an open-market trade.

After these transactions, he directly holds 105,456 shares of common stock, which include 679 restricted stock units, and 47,580 stock options that remain outstanding and fully vested. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.

Life360, Inc. director John Philip Coghlan reported indirect open-market sales of 4,000 shares of common stock on May 1, 2026. The shares, held by the John Coghlan Living Trust, were sold in two transactions at weighted average prices of $44.12 and $44.67 per share. These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. Following the transactions, the trust held 32,431 shares, a separate 2025 Grantor Retained Annuity Trust held 55,494 shares, and Coghlan also reported 836 restricted stock units, each representing one future share upon vesting.

Life360, Inc. director Chris Hulls reported a routine mix of equity transactions tied to compensation. He exercised stock options to acquire 27,000 shares of common stock at $8.19 per share, then had 6,945 shares withheld to cover income tax obligations on vested restricted stock units.

He also completed an open‑market sale of 16,105 shares at a weighted average price of $45.51 under a pre‑established Rule 10b5‑1 trading plan. Following these transactions, Hulls directly holds 399,809 shares of common stock, with additional indirect holdings through three 2023 irrevocable trusts, each reported with 195,312 shares, plus previously granted restricted stock units and CDIs representing further common stock exposure.

Life360, Inc. Chief Financial Officer Russell John Burke reported a routine tax-withholding share disposition related to vesting restricted stock units. On this date, 2,193 shares of common stock were withheld by the company at $39.78 per share to cover income tax obligations, rather than sold in the open market.

Following this withholding, Burke directly holds 122,061 shares of Life360 common stock and indirectly holds 113,361 shares through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust as tenants in common. His position also includes 118,188 restricted stock units, each representing a contingent right to receive one share upon vesting.

Life360, Inc. Chief Executive Officer Lauren Antonoff reported a small tax-related share sale. On this Form 4, she sold 2,716 shares of common stock at $45.231 per share in an open-market transaction.

According to the footnotes, this sale was made solely to cover tax withholding obligations triggered by the vesting and settlement of previously reported restricted stock units through a “sell-to-cover” arrangement, and is described as non-discretionary. Following the sale, she directly holds 309,781 shares of common stock, and the total includes 161,566 RSUs previously granted that each represent a contingent right to receive one share upon vesting.

Burke Russell John reported acquisition or exercise transactions in this Form 4 filing.

Life360, Inc.’s Chief Financial Officer Russell John Burke reported a grant of 43,416 restricted stock units (RSUs), each representing a right to receive one share of common stock upon settlement. The RSUs vest in equal monthly installments, with 1/48th vesting each month starting on January 1, 2026, subject to his continued service.

Following this grant, he holds 124,254 RSUs directly and also has an indirect holding of 113,361 shares of common stock through revocable trusts. This filing reflects compensation-related equity awards rather than open‑market share purchases or sales.

Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at $11.18 per share and then sold 7,930 shares at $37.27 per share on the same day. The filing shows he directly holds 105,456 common shares afterward, which include 679 restricted stock units previously granted. The stock option exercised was fully vested and exercisable and is now fully used. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.

Life360, Inc. director John Philip Coghlan reported an open-market sale of 4,000 shares of common stock at a weighted average price of $41.32 per share. The shares were sold by the John Coghlan Living Trust under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025.

After this sale, the John Coghlan Living Trust held 36,431 shares of Life360 common stock. Separate from the trust, Coghlan also reported 836 restricted stock units directly and 55,494 shares held indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust.

Life360 director Alex Haro exercised stock options to acquire additional common shares. He exercised options covering 144,533 shares of Life360, Inc. common stock across three grants at exercise prices of $2.15, $8.19 and $13.35 per share. These exercises converted derivative awards into outright share ownership and left no remaining balance in the exercised option grants. Following the transactions, Haro directly owned 1,005,848 shares of common stock. This direct position includes 679 restricted stock units, each representing a right to receive one share of common stock upon vesting.

Life360, Inc. Chief Financial Officer Russell John Burke reported an equity award linked to performance-based restricted stock units. On March 25, 2026, a performance metric tied to PRSUs granted on April 9, 2025 was determined to be satisfied, triggering acquisition of 24,265 shares of common stock at no cost.

Each PRSU represents a right to receive one share upon settlement. According to the filing, 25% of these PRSUs vested on January 1, 2026, with the remaining 75% converted to time-based RSUs that will vest in twelve equal quarterly installments, subject to continued service. Following this and prior grants, Burke holds 80,838 restricted stock units directly and 113,361 shares indirectly through the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust ELD as tenants in common, reflecting both direct and trust-based ownership. The filing also notes an exempt transfer of 22,284 directly held shares into this trust structure.

Life360 director Chris Hulls reported an award of 54,595 shares of common stock tied to performance-based restricted stock units. The PRSUs were granted on April 9, 2025 and became reportable when the performance metric was determined to be met on March 25, 2026.

Each PRSU represents a right to receive one share of common stock upon settlement. Twenty-five percent vested on January 1, 2026, and the remaining 75% converted to time-based RSUs that vest in twelve equal quarterly installments, subject to continued service. After this award, Hulls directly holds 388,914 shares, and separate 2023 irrevocable trusts bearing family names each hold 195,312 shares as indirect positions.

Life360, Inc. Chief Executive Officer Lauren Antonoff reported an equity award tied to performance. She acquired 24,265 shares of common stock at no cost through performance-based restricted stock units after a performance metric was met. Following this grant, she directly holds 312,497 shares, including earlier restricted stock unit awards.

Life360, Inc. director Chris Hulls reported an option exercise and related share sale. He exercised stock options for 27,000 shares of common stock at an exercise price of $8.19 per share, then sold 15,133 shares of common stock at a weighted average price of $39.43 per share.

Following these transactions, Hulls directly holds 334,319 shares of common stock and also reports indirect holdings through 2023 irrevocable trusts. The filing notes that the sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 16, 2025, and that 108,371 restricted stock units are included in his reported holdings.

Life360, Inc. director Synge James reported a bona fide gift of 8,333 shares of common stock on March 17, 2026. The transfer was made for charitable purposes and involved no sale proceeds. After this gift, James holds 186,421 shares of common stock, including shares underlying Chess Depositary Interests and 703 restricted stock units.

Life360, Inc. director David Wiadrowski reported an option exercise and related share sale. On March 13, 2026, he exercised stock options for 21,310 shares of common stock, including 13,850 shares at an exercise price of $13.35 and 7,460 shares at $8.19 per share.

The filing shows an open-market sale of 5,957 shares of common stock at a weighted average price of $41.34 per share, with footnotes stating these shares were sold solely to cover the option exercise cost. After these transactions, he directly owned 39,679 shares of common stock, which includes 738 restricted stock units that will convert into shares upon vesting.

Life360, Inc. director Charles J. Prober reported an exercise-and-sell transaction involving 7,930 shares. On 2026-03-13, he exercised stock options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share, then sold 7,930 shares of common stock at $41.40 per share in an open-market transaction.

The activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-03-14. After these transactions, Prober directly held 105,456 shares of common stock, including 679 restricted stock units that each represent a right to receive one share upon vesting.

Life360 director John Philip Coghlan, through the John Coghlan Living Trust, reported open-market sales of 4,000 shares of common stock on March 9, 2026. The shares were sold in two trades at weighted average prices of $45.29 and $46.56 per share.

The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, meaning they were scheduled in advance. After these transactions, the trust held 5,065 shares, while Coghlan also held 36,202 shares directly and 55,494 shares indirectly through a separate grantor retained annuity trust, including 836 restricted stock units.

Life360, Inc. Chief Financial Officer Russell John Burke reported a routine equity compensation event. On the vesting and net settlement of previously granted restricted stock units, 5,800 shares of common stock were withheld by the company to satisfy income tax withholding and remittance obligations, and this is explicitly not a sale by the executive.

Following this tax-withholding disposition, Burke holds 78,857 shares of common stock directly and 91,077 shares indirectly through the Russell John Burke Revocable Trust. These indirect holdings include 56,573 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting.

Life360, Inc. director Chris Hulls reported a routine tax-related share disposition. On March 6, 2026, 5,248 shares of common stock were withheld by the company at $44.91 per share to satisfy income tax obligations tied to vesting restricted stock units, and were not sold in the open market. After this withholding, Hulls held 322,452 shares directly, a figure that includes common stock, shares underlying Chess Depositary Interests, and 108,371 unvested restricted stock units. The filing also shows indirect holdings of 195,312 shares each in three separate 2023 irrevocable trusts.

Life360, Inc. Chief Executive Officer Lauren Antonoff sold 17,153 shares of common stock at $44.86 per share. According to the disclosure, this was a sell-to-cover transaction to satisfy tax withholding obligations from vesting RSUs, not a discretionary sale. After the sale, Antonoff directly held 288,232 shares and had 143,367 RSUs outstanding.

Life360, Inc. director John Philip Coghlan exercised a stock option and acquired 31,938 shares of common stock at $0.18 per share through a derivative exercise on March 5, 2026. After this transaction, he directly holds 36,202 shares of common stock, which includes 1,672 restricted stock units that each represent a contingent right to receive one share upon vesting.

He also has indirect ownership of common stock, with 9,065 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The reported numbers were adjusted because a previously reported transfer of 1,672 directly held shares to the living trust has not yet occurred.